Cannabis Markets Primed for Robust Growth as Global Spending Projected to Reach $57 Billion

Thursday, April 19, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

PALM BEACH, Florida, April 18, 2018 /PRNewswire/ -- News Commentary 


global cannabis industry is in a position to significantly expand and enhance operations as spending is projected to increase drastically over the next decade, according to a study conducted by Arcview Market Research. The study forecasts spending on
legal cannabis to near $60 billion by 2027, thus necessitating bolstered operations as industry leaders aim to keep up with the steadily rising global demand. Canada's green rush is on building real excitement that may be attributed to the expected legalization of recreational marijuana in the Country by this coming summer. With expansion nearing, Canadian marijuana growers have been pouring growing amounts of operating cash flow and capital to expand production capacity. Active cannabis stocks in the markets include:Choom™ Holdings Inc. (CSE: CHOO) (OTC: CHOOF), Emblem Corp. (TSX-V: EMC) (OTC: EMMBF), MedReleaf Corp. (TSX: LEAF) (OTC: MEDFF), National Access Clinic Corp. (TSX-V: NAC) (OTC: NACNF), Invictus MD Strategies Corp. (TSX-V: GENE) (OTC: IVITF).

Choom™ Holdings Inc.  (CSE: CHOO) (OTC: CHOOF) BREAKING NEWS:  Choom™ has applied to Saskatchewan Liquor and Gaming Authority ("SLGA") for cannabis retail permits in 32 Zones across the province. The SLGA has made 51 cannabis retail permits available in 32 zones through a Request for Proposal process and is expected to award the permits via lottery by June, 2018.

Additionally, Choom™ has secured the rights to 16 retail locations in Alberta and British Columbia, in all cases, subject to all necessary governmental approvals being granted. This number is excepted to grow over the coming months as the Company is currently negotiating additional leases with the intention of submitting applications for retail licenses.  

"This is a significant step towards delivering the Choom™ experience of 'good times with good friends' for Canadians across the country," states Choom's president and CEO, Chris Bogart. "We have now established a footprint to position Choom™ as a leading private cannabis retailer in Western Canada. We will continue to pursue retail licensing opportunities across the country and remain committed to serving all Canadians in the coming consumer cannabis market. Choom's vision of delivering an elevated customer experience through our curated retail environments, with the creation of modern, stylish storefronts is well underway." Read this and more news for Choom™ at: Additional industry related developments from around the markets:

Emblem Corp. (TSX-V: EMC.V) (OTC: EMMBF) and Durham College (DC), on behalf of its health and education subsidiary GrowWise Health Limited (GrowWise), are partnering to develop and launch the Cannabis Industry Specialization certification fall 2018. The first of its kind in Ontario, the part-time studies program will be delivered both in class and online via simulcast. It is designed to prepare professionals with business experience or who have already completed a diploma or degree in business to pursue a career in the rapidly growing cannabis sector. "The long-term success of Canada's cannabis industry will depend strongly on there being a skilled workforce to support and advance it," said Adam Saperia, president, GrowWise. "Together, GrowWise and Durham College are ensuring that the right education and training are available to those who are interested in entering this exciting field."

MedReleaf Corp. (TSX: LEAF.TO) (OTC: MEDFF) recently announced the appointments of Umar Syed as Senior Vice President of Corporate Development and Andy Duncan as Vice President of Engineering. In addition to these appointments, Eitan Popper has stepped down from his position as President of MedReleaf, effective immediately. These senior leadership team changes add depth and experience from the pharmaceutical industry as part of MedReleaf's global strategy. Mr. Syed brings over 27 years of experience in the healthcare and pharmaceutical industry and was most recently at Pharmascience Inc., among Canada's largest pharmaceutical companies with distribution in over 60 countries. Mr. Duncan has over 20 years of engineering and infrastructure development experience primarily at Apotex Inc., Canada's largest generic pharmaceutical company with a global operation and exports to over 115 countries.

National Access Clinic Corp. (TSX-V: NAC.V) (OTC: NACNF) and The Second Cup Ltd. ("Second Cup") (SCU.TO), Canada's second-largest retailer of specialty coffee, recently announced that they have established a strategic alliance to develop and operate a network of NAC-branded recreational cannabis dispensaries initially across Western Canada , expanding to include additional provinces where legally permissible. NAC will apply for licenses to dispense cannabis products and upon receipt, work with Second Cup and applicable franchisees to leverage Second Cup's extensive Canadian retail footprint to construct retail stores carrying leading cannabis products, including products supplied by CannaRoyalty Corp. (CSE:CRZ) (OTC: CNNRF) ("CannaRoyalty"), California's largest legal distributor of cannabis products. Conversion of any Second Cup café to an NAC-branded recreational cannabis dispensary will be conditional on obtaining a retail license from provincial regulators and the approval of Second Cup and the applicable franchisee and landlord.

Invictus MD Strategies Corp. (TSX-V: GENE.V) (OTC: IVITF) recently announced that Acreage Pharms Ltd ("Acreage Pharms") has received 23 new strains, providing the Company with a broad cannabis cultivation profile including: strains that are high in CBD; strains that offer especially elevated concentrations of THC; and strains that capture a wide variety of terpenes and cannabinoids, increasingly sought after by cannabis consumers. "The Acreage Pharms team continues to produce more genetics through its selective breeding program to further improve its cultivation biodiversity - a key step towards ensuring the breadth and longevity of our lines for medical and recreational markets," said Invictus Chairman and CEO Dan Kriznic. "Cultivating a generous suite of high-quality cannabis is complex, demanding work. It requires savviness in fields like plant biology, irrigation and lighting, as well as an intimate understanding of pests and diseases and how to vanquish them naturally - no pesticides or herbicides. Acreage Pharms is taking so many smart steps, and of course the team led by Acreage Pharms CEO Trevor Dixon , continues to invest in new strains and will continue to do so across this historic year and beyond. It is thrilling.".

DISCLAIMER: (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated forty five hundred dollars for news coverage of the current press release issued above by Choom™ Holdings Inc. by a non affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Media Contact: email: +1(561)325-8757


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store